Optimized strategy to improve the outcomes of acute type A aortic dissection with malperfusion syndrome

医学 主动脉夹层 阶段(地层学) 外科 解剖(医学) 心脏病学 内科学 主动脉 古生物学 生物
作者
Shuangkun Chen,Hua Peng,Hui Zhuang,Juxiang Wang,Pianpian Yan,Weiqun Zhang,Weiliang Zheng,Mingyu Li,Xijie Wu
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [American Association for Thoracic Surgery]
被引量:3
标识
DOI:10.1016/j.jtcvs.2024.01.006
摘要

The mortality of acute type A aortic dissection (ATAAD) with malperfusion syndrome (MPS) is high. However, the management strategy remains controversial. We aimed to evaluate the strategy for MPS at our institution.Among 724 patients with ATAAD, 167 patients with MPS were treated with immediate central repair (1st stage) or an optimized strategy (2nd stage). In 2nd stage, the optimized strategy used was based on 6-hour threshold from symptom onset. For MPS with symptom onset within 6 hours, immediate central repair was performed followed by endovascular reperfusion if malperfusion persisted. With symptom onset beyond 6 hours, individualized delayed central repair was performed. We compared outcomes between the 1st and 2nd stage.The in-hospital mortality of ATAAD was significantly decreased when the optimized strategy was used (4.3% in 2nd stage vs. 12.5% in 1st stage, P<0.01). In 2nd stage, the in-hospital mortality for MPS was decreased (10.2% vs. 33.9%, P<0.01). Moreover, the in-hospital mortality for MPS with symptom onset within or beyond 6 hours decreased from 24% to 7.5% and from 41.2% to 11.8%, respectively. The operative mortality of MPS in 2nd stage was comparable with patients without MPS (4.0% vs. 2.4%, P>0.05).The optimized strategy significantly improved the outcomes of MPS. The 6-hour threshold from symptom onset could be very useful in determining the timing of central repair. For MPS with symptom onset within 6 hours, immediate central repair is reasonable. For those with symptom onset beyond 6 hours, individualized delayed central repair should be considered.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
unicornmed发布了新的文献求助10
刚刚
可爱的函函应助茶艺如何采纳,获得10
1秒前
江知之完成签到 ,获得积分0
1秒前
1秒前
3秒前
刻苦问柳发布了新的文献求助10
3秒前
酷酷平卉完成签到 ,获得积分10
3秒前
星辰大海应助吴吴采纳,获得30
3秒前
JTB发布了新的文献求助10
3秒前
BILNQPL发布了新的文献求助10
3秒前
兮遥遥完成签到 ,获得积分10
4秒前
4秒前
4秒前
丰知然应助轩辕德地采纳,获得10
5秒前
6秒前
吨吨喝水关注了科研通微信公众号
6秒前
酷波er应助某只橘猫君采纳,获得10
6秒前
6秒前
stt发布了新的文献求助10
6秒前
6秒前
Ling完成签到,获得积分10
6秒前
TanFT完成签到,获得积分10
7秒前
笙歌自若发布了新的文献求助10
7秒前
7秒前
CipherSage应助积极的凌波采纳,获得10
8秒前
8秒前
烟花应助欣慰硬币采纳,获得10
8秒前
老大爷滴滴完成签到,获得积分10
8秒前
8秒前
8秒前
SciGPT应助LEMON采纳,获得10
9秒前
搜集达人应助叶飞荷采纳,获得10
9秒前
wxy完成签到,获得积分10
9秒前
10秒前
弄香完成签到,获得积分10
10秒前
gguc完成签到,获得积分10
10秒前
10秒前
无聊又夏完成签到,获得积分10
11秒前
今后应助木野狐采纳,获得10
11秒前
12秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527723
求助须知:如何正确求助?哪些是违规求助? 3107826
关于积分的说明 9286663
捐赠科研通 2805577
什么是DOI,文献DOI怎么找? 1539998
邀请新用户注册赠送积分活动 716878
科研通“疑难数据库(出版商)”最低求助积分说明 709762